WO2004101834A2 - Treatment of base metal concentrate by a two-step bioleaching process - Google Patents

Treatment of base metal concentrate by a two-step bioleaching process Download PDF

Info

Publication number
WO2004101834A2
WO2004101834A2 PCT/ZA2004/000052 ZA2004000052W WO2004101834A2 WO 2004101834 A2 WO2004101834 A2 WO 2004101834A2 ZA 2004000052 W ZA2004000052 W ZA 2004000052W WO 2004101834 A2 WO2004101834 A2 WO 2004101834A2
Authority
WO
WIPO (PCT)
Prior art keywords
bioleaching
primary
thermophilic
concentrate
base metal
Prior art date
Application number
PCT/ZA2004/000052
Other languages
French (fr)
Other versions
WO2004101834A3 (en
Inventor
Clint Bowker
Paul Harvey
Original Assignee
Bhp Billiton Sa Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bhp Billiton Sa Limited filed Critical Bhp Billiton Sa Limited
Priority to US10/557,410 priority Critical patent/US20070028721A1/en
Priority to AP2005003447A priority patent/AP1973A/en
Priority to AU2004239345A priority patent/AU2004239345B2/en
Priority to CA 2526104 priority patent/CA2526104A1/en
Publication of WO2004101834A2 publication Critical patent/WO2004101834A2/en
Publication of WO2004101834A3 publication Critical patent/WO2004101834A3/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C22METALLURGY; FERROUS OR NON-FERROUS ALLOYS; TREATMENT OF ALLOYS OR NON-FERROUS METALS
    • C22BPRODUCTION AND REFINING OF METALS; PRETREATMENT OF RAW MATERIALS
    • C22B15/00Obtaining copper
    • C22B15/0063Hydrometallurgy
    • CCHEMISTRY; METALLURGY
    • C22METALLURGY; FERROUS OR NON-FERROUS ALLOYS; TREATMENT OF ALLOYS OR NON-FERROUS METALS
    • C22BPRODUCTION AND REFINING OF METALS; PRETREATMENT OF RAW MATERIALS
    • C22B11/00Obtaining noble metals
    • C22B11/04Obtaining noble metals by wet processes
    • CCHEMISTRY; METALLURGY
    • C22METALLURGY; FERROUS OR NON-FERROUS ALLOYS; TREATMENT OF ALLOYS OR NON-FERROUS METALS
    • C22BPRODUCTION AND REFINING OF METALS; PRETREATMENT OF RAW MATERIALS
    • C22B15/00Obtaining copper
    • C22B15/0063Hydrometallurgy
    • C22B15/0084Treating solutions
    • C22B15/0089Treating solutions by chemical methods
    • CCHEMISTRY; METALLURGY
    • C22METALLURGY; FERROUS OR NON-FERROUS ALLOYS; TREATMENT OF ALLOYS OR NON-FERROUS METALS
    • C22BPRODUCTION AND REFINING OF METALS; PRETREATMENT OF RAW MATERIALS
    • C22B3/00Extraction of metal compounds from ores or concentrates by wet processes
    • C22B3/18Extraction of metal compounds from ores or concentrates by wet processes with the aid of microorganisms or enzymes, e.g. bacteria or algae
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P10/00Technologies related to metal processing
    • Y02P10/20Recycling

Definitions

  • This invention relates to the treatment of a base metal containing concentrate.
  • US patent No. 6,461,577 addresses the problem of arsenic toxicity of extremely thermophilic bacterial cultures by means of a two-stage leaching process.
  • a major part of the arsenic contained in the material being treated is leached from the material and then oxidised from As(lll) to As(V).
  • the remaining leachable metal content of the material being treated is leached out in a second thermophilic stage.
  • the concentration of pentavalent arsenic falls quickly and the toxic effect thereof on the thermophilic bacteria thus falls at the same rate.
  • the invention provides a method of treating a concentrate containing at least one base metal which includes the steps of subjecting the concentrate to a primary mesophilic and moderate thermophilic bioleaching process to leach sulphides in the concentrate, processing a residue of the primary bioleach process to recover at least one metal from the primary bioleach residue, subjecting a residue from the metal recovery process to a thermophilic secondary bioleaching process to release the at least one base metal from the metal recovery residue into solution, and recovering the at least one base metal at least from the solution produced by the thermophilic secondary bioleaching process.
  • the primary bioleaching process may be carried out at a temperature of from 35°C to 50°C.
  • the at least one base metal is also recovered from a solution produced by the primary bioleach bioleaching process.
  • the method preferably includes the step of preleaching the concentrate, before the primary bioleach bioleaching process, using leach solution from at least one of the bioleaching processes.
  • the leach solution is derived from the primary bioleaching process and the thermophilic secondary bioleaching process.
  • the preleaching step is used to remove easily leachable base metal from the concentrate before the primary bioleaching process. Elemental sulphur which may accumulate during the preleach step due to rapid leaching of easily leachable sulphides, may be removed during the bioleaching stages, especially during the thermophilic secondary bioleaching process at elevated temperatures.
  • the primary bioleaching process may be carried out in a series of continuously stirred tank reactors which are operated at a temperature of from 35°C to 50°C in the presence of an active mixed culture of mesophilic and moderate thermophilic microorganisms.
  • a mixed culture of mesophile (20°C to 40°C) and moderate thermophile (40°C to 55°C) microorganisms is preferably used to maximise sulphide bioleaching and sulphur biooxidation during the treatment process.
  • the mixed culture may contain microorganisms like Leptospirillum ferrooxidans and Acidithiobacillus caldus, a good iron oxidiser and a good sulphur oxidiser respectively.
  • the primary bioleach process may also contain thermophilic microorganisms, which are not effectively active at the temperature range of 35°C to 50°C. Such microorganisms will, however, still be living but will be dormant or slowly metabolising. When the temperature increases during the thermophilic secondary bioleaching process these microorganisms will reactivate their activity. This may be very useful for base metal concentrates, as the thermophilic secondary bioleaching stage would be continuously re-inoculated.
  • the pH of the concentrate or pulp in reactors in which the primary bioleaching is carried out may be controlled at a value of from 1 ,2 to 1 ,7. This may be achieved by the addition of limestone or raffinate produced in the base metal recovery step, to the reactors.
  • Oxygen may be supplied to the concentrate in the reactors in the form of enriched air which may contain from 95% to 98% oxygen, during at least part of the bioleaching processes.
  • An objective of operating the primary bioleaching process under the aforementioned conditions is to maximise the leaching of the sulphides in the concentrate and to maximise mass loss, and to minimise the precipitation in pentavalent form of arsenic which may be present in solution.
  • the product from the primary bioleach residue may contain high concentrations of elemental sulphur due to the maximised bioleaching conditions.
  • toxic silver may be removed from the primary bioleaching residue.
  • the silver may be removed using a brine leaching process.
  • thermophilic secondary bioleaching process may be carried out in a series of continuously stirred tank reactors at a temperature of from 65°C to 80°C in the presence of active quantities of extreme thermophilic microorganisms.
  • the method may include the step of controlling the pH of the pulp in the thermophilic reactors at a value of from 1 virgin0 to 1 ,7. This may be achieved by the addition of limestone or raffinate produced in the metal recovery step.
  • Oxygen & carbon dioxide may be supplied to the reactors in the form of enriched gas containing from 95% to 98% oxygen and 1 % to 5% carbon dioxide.
  • thermophilic secondary bioleaching process under the aforementioned parameters is to maximise the oxidation of sulphides minerals and mass loss, and to minimise the precipitation in pentavalent form of arsenic which may be present in solution.
  • thermophilic temperature conditions Furthermore sulphur oxidation at thermophilic temperature conditions is maximised and thus any elemental sulphur produced during the proceeding pre- leach and primary bioleach may be fully oxidised. This is very important if further treatment of the thermophilic secondary bioleach residue is required for precious group metals (PGM's) recovery like gold. Elemental sulphur increases cyanide consumption during cyanidation to recover gold and thus contributes significantly to the increase in cyanidation costs. Additionally, elemental sulphur not oxidised decreases the acid produced in the bioleach solution and thus may decrease the effectiveness of any preleach step using recycled bioleach solution.
  • PGM's precious group metals
  • the at least one base metal is recovered from the leach solutions produced by the bioleaching processes.
  • the pH of the solution produced in the preleaching step is adjusted to maximise recovery of the at least one base metal using solvent extraction techniques.
  • Arsenic present in the solution may be caused to precipitate as ferric arsenate by increasing the pH of the solution to at least 2.
  • the pH of the solution may be increased by the addition of limestone slurry to the solution.
  • the pH adjustment may be carried out in a series of continuously stirred tank reactors which are operated at a temperature of from 60°C to 80°C.
  • the at least one base metal eg. copper
  • the at least one base metal may be recovered by concentrating the copper and stripping, followed by cathode production by electrowinning.
  • a concentrate 10 which contains a base metal such as copper and which may have a high arsenic content is subjected to a preleaching step 12.
  • the fresh concentrate is contacted with bioleach overflow solutions 14 and 16 respectively produced in subsequent primary and thermophilic secondary bioleaching stages 18 and 20.
  • the solutions 14 and 16 are rich in ferric and remove easily leachable copper from the feed 10. This ensures a lower residual copper tenor in the bioleaching tanks in the stages 18 and 20.
  • An overflow solution 26 from the separation step 24 is directed to a pH adjustment stage 28 while the underflow 30, diluted with water 32 and raffinate 34 from a solvent extraction section 36, is fed to the primary bioleaching stage 18.
  • the purpose of the primary bioleaching stage 18 is to oxidise sulphide minerals in the feed and release base metals of interest into solution.
  • the bioleaching is carried out in a series of continuously stirred tank reactors which are operated at a temperature of 35°C to 50°C in the presence of active quantities of mesophilic and moderate thermophilic microorganisms.
  • the pH of the pulp of the reactors in the primary bioleaching stage is controlled at a value of from 1 ,2 to 1 ,7 by the addition of limestone 40 or raffinate 34.
  • Oxygen 42 required for the oxidative reaction, is supplied in the form of enriched air with an oxygen content of from 95% to 98%.
  • the product 44 of the primary bioleaching section 18 reports to bioleach thickening and washing 46. As has been indicated the overflow solution 14 is fed to the preleaching step 12 while the underflow 48 is the feed to a metal recovery section 50.
  • the purpose of the step 46 is to separate the liquids and the solids so that the base metals of interest and arsenic, if present, report to the pH adjustment section 28 via the preleaching step 12.
  • toxic silver 52 is removed from the primary bioleaching residue 48 using a brine leaching or other suitable method.
  • thermophilic secondary bioleaching stage 20 The residue 54 from the metal recovery step is repulped with water 56 and raffinate 34 and the resulting slurry is fed to the thermophilic secondary bioleaching stage 20.
  • stage 20 The purpose of the stage 20 is to oxidise, to the extent possible, the sulphide minerals and the elemental sulphur which were not leached in the primary bioleaching stage 18. The base metals of interest are thereby released into solution.
  • the thermophilic secondary bioleaching process is carried out in a series of continuously stirred tank reactors which are operated at a temperature of from 65°C to 80°C in the presence of active quantities of extreme thermophilic microorganisms.
  • the pH of the pulp in the thermophilic reactors is controlled at a value of from 1 ,0 to 1 ,7 by the addition of limestone 40 or raffinate 34.
  • Oxygen 42 required for the oxidative reactions is supplied in the form of enriched gas with an oxygen content of from 95% to 98%.
  • Carbon dioxide 57 may be required for improved thermophilic cell growth is supplied in the form of enriched gas with a carbon dioxide content of 1% to 5% by volume.
  • thermophilic bioleaching section 20 reports to a bioleach thickening and washing step 62.
  • the overflow solution 16 is fed to the preleaching section 12 while the underflow 64 is directed to a tailings pond 66 for disposal. If the underflow 64 contains PGM's then the underflow is directed to a metal recovery step 67 where the metal is removed from the underflow using cyanide as a leaching process for gold or other suitable method.
  • the purpose of the step 62 is to separate liquid and solids so that base metals of interest and arsenic, if present, are reported in solution to the pH adjustment section 28 via the preleaching stage 12.
  • the pH adjustment section 28 includes a series of continuously stirred tank reactors which are operated at a temperature of from 60°C to 80°C.
  • the pH of the solution 26 is increased to a required level using limestone 40 or any other suitable neutralising agent.
  • the product 70 of the pH adjustment section is then thickened in a step 72.
  • the thickener underflow 74 which contains precipitated ferric arsenate, is directed to a tailings pond 76 for disposal.
  • the overflow from the thickener step reports as pregnant leach solution (PLS) 80 to the solvent extraction section 36.
  • the purpose of the pH adjustment section 28 is to increase the pH of the pregnant leach solution, which is fed to the solvent extraction section 36, to above 2,0 so that the solvent extraction efficiency is maximised.
  • Arsenic which- is present in : the solution 26 is caused, by the increase in the pH, to precipitate primarily as ferric arsenate which is not readily dissolved. The ferric arsenate passes EPA limits and is safe for land disposal.
  • the base metal containing concentrate is subjected to primary mesophilic and or moderate thermophilic leaching, metal recovery and thermophilic secondary leaching in combination so that secondary sulphides are successfully and economically leached in the primary section, toxic silver is removed in the metal recovery section, and a residue containing unleached primary sulphides and elemental sulphur is leached to completion successfully and economically in the thermophile secondary section.
  • arsenic is present in the concentrate the primary and thermophilic secondary sections are operated so that the redox potential of the solutions produced result in the natural oxidation of As(lll) to As(V).
  • Arsenic precipitation in the bioleaching sections is intentionally minimised so that the arsenic is precipitated externally in the pH adjustment section 28. This avoids the production of a bioleach residue contaminated with arsenic.
  • thermophilic stage 20 It is cost effective to reduce the arsenic reporting to the thermophilic stage 20 by causing the arsenic to precipitate in a separate dedicated process step ie. the pH adjustment section 28. By minimising precipitation in the mesophilic stage 18 the mass loss throughout the process is maximised. This reduces the capital and operating cost of the downstream processes including the thermophilic section 20.
  • thermophilic temperature conditions Furthermore sulphur oxidation at thermophilic temperature conditions is maximised and thus any elemental sulphur produced during the proceeding preleach and primary bioleach may be fully oxidised. This is important if further treatment of the thermophilic secondary bioleach residue is required for precious group metals (PGM's) recovery like gold. Elemental sulphur increases cyanide consumption during cyanidation to recover gold and thus contributes significantly to the increase in cyanidation costs. Additionally, elemental sulphur not oxidised decreases the acid produced in the bioleach solution and thus may decrease the effectiveness of any preleach step using recycled bioleach solution.
  • PGM's precious group metals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Manufacturing & Machinery (AREA)
  • Materials Engineering (AREA)
  • Mechanical Engineering (AREA)
  • Metallurgy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Environmental & Geological Engineering (AREA)
  • General Life Sciences & Earth Sciences (AREA)
  • Geochemistry & Mineralogy (AREA)
  • Geology (AREA)
  • Manufacture And Refinement Of Metals (AREA)
  • Processing Of Solid Wastes (AREA)
  • Extraction Or Liquid Replacement (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

A bio-leach method of recovering at least one base metal from sulphidic or a concentrate wherein a residue of a primary bioleach of the concentrate, under mesophilic and moderate themophilic conditions, is processed to recover at least one metal, for instance copper, is recovered from a solution, produced by a secondary bioleach under thermophilic conditions, of a residue of the metal recovery process.

Description

TREATMENT OF BASE METAL CONCENTRATE
BACKGROUND OF THE INVENTION
[0001] This invention relates to the treatment of a base metal containing concentrate.
[0002] The recovery of a base metal such as copper from a concentrate, which contains arsenic, using a bioleaching process, can be problematic for it is necessary to avoid producing a bioleach residue which is contaminated with arsenic.
[0003] US patent No. 6,461,577 addresses the problem of arsenic toxicity of extremely thermophilic bacterial cultures by means of a two-stage leaching process. In a first mesophilic stage a major part of the arsenic contained in the material being treated is leached from the material and then oxidised from As(lll) to As(V). The remaining leachable metal content of the material being treated is leached out in a second thermophilic stage. The concentration of pentavalent arsenic falls quickly and the toxic effect thereof on the thermophilic bacteria thus falls at the same rate.
[0004] It is desirable though to remove the soluble arsenic as ferric arsenate which passes EPA limits and is safe for land disposal and which, to the extent possible, is not in a bioleach residue.
SUMMARY OF INVENTION
[0005] The invention provides a method of treating a concentrate containing at least one base metal which includes the steps of subjecting the concentrate to a primary mesophilic and moderate thermophilic bioleaching process to leach sulphides in the concentrate, processing a residue of the primary bioleach process to recover at least one metal from the primary bioleach residue, subjecting a residue from the metal recovery process to a thermophilic secondary bioleaching process to release the at least one base metal from the metal recovery residue into solution, and recovering the at least one base metal at least from the solution produced by the thermophilic secondary bioleaching process.
[0006] The primary bioleaching process may be carried out at a temperature of from 35°C to 50°C.
[0007] Preferably the at least one base metal is also recovered from a solution produced by the primary bioleach bioleaching process.
[0008] The method preferably includes the step of preleaching the concentrate, before the primary bioleach bioleaching process, using leach solution from at least one of the bioleaching processes. Preferably the leach solution is derived from the primary bioleaching process and the thermophilic secondary bioleaching process.
[0009] The preleaching step is used to remove easily leachable base metal from the concentrate before the primary bioleaching process. Elemental sulphur which may accumulate during the preleach step due to rapid leaching of easily leachable sulphides, may be removed during the bioleaching stages, especially during the thermophilic secondary bioleaching process at elevated temperatures.
[0010] The primary bioleaching process may be carried out in a series of continuously stirred tank reactors which are operated at a temperature of from 35°C to 50°C in the presence of an active mixed culture of mesophilic and moderate thermophilic microorganisms.
[0011] A mixed culture of mesophile (20°C to 40°C) and moderate thermophile (40°C to 55°C) microorganisms is preferably used to maximise sulphide bioleaching and sulphur biooxidation during the treatment process. The mixed culture may contain microorganisms like Leptospirillum ferrooxidans and Acidithiobacillus caldus, a good iron oxidiser and a good sulphur oxidiser respectively.
[0012] The primary bioleach process may also contain thermophilic microorganisms, which are not effectively active at the temperature range of 35°C to 50°C. Such microorganisms will, however, still be living but will be dormant or slowly metabolising. When the temperature increases during the thermophilic secondary bioleaching process these microorganisms will reactivate their activity. This may be very useful for base metal concentrates, as the thermophilic secondary bioleaching stage would be continuously re-inoculated.
[0013] The pH of the concentrate or pulp in reactors in which the primary bioleaching is carried out may be controlled at a value of from 1 ,2 to 1 ,7. This may be achieved by the addition of limestone or raffinate produced in the base metal recovery step, to the reactors.
[0014] Oxygen may be supplied to the concentrate in the reactors in the form of enriched air which may contain from 95% to 98% oxygen, during at least part of the bioleaching processes. [0015] An objective of operating the primary bioleaching process under the aforementioned conditions is to maximise the leaching of the sulphides in the concentrate and to maximise mass loss, and to minimise the precipitation in pentavalent form of arsenic which may be present in solution. The product from the primary bioleach residue may contain high concentrations of elemental sulphur due to the maximised bioleaching conditions.
[0016] In the metal recovery process toxic silver may be removed from the primary bioleaching residue. The silver may be removed using a brine leaching process.
[0017] The thermophilic secondary bioleaching process may be carried out in a series of continuously stirred tank reactors at a temperature of from 65°C to 80°C in the presence of active quantities of extreme thermophilic microorganisms.
[0018] The method may include the step of controlling the pH of the pulp in the thermophilic reactors at a value of from 1„0 to 1 ,7. This may be achieved by the addition of limestone or raffinate produced in the metal recovery step. Oxygen & carbon dioxide may be supplied to the reactors in the form of enriched gas containing from 95% to 98% oxygen and 1 % to 5% carbon dioxide.
[0019] An objective of operating the thermophilic secondary bioleaching process under the aforementioned parameters is to maximise the oxidation of sulphides minerals and mass loss, and to minimise the precipitation in pentavalent form of arsenic which may be present in solution.
[0020] Furthermore sulphur oxidation at thermophilic temperature conditions is maximised and thus any elemental sulphur produced during the proceeding pre- leach and primary bioleach may be fully oxidised. This is very important if further treatment of the thermophilic secondary bioleach residue is required for precious group metals (PGM's) recovery like gold. Elemental sulphur increases cyanide consumption during cyanidation to recover gold and thus contributes significantly to the increase in cyanidation costs. Additionally, elemental sulphur not oxidised decreases the acid produced in the bioleach solution and thus may decrease the effectiveness of any preleach step using recycled bioleach solution.
[0021] As indicated the at least one base metal is recovered from the leach solutions produced by the bioleaching processes. Preferably the pH of the solution produced in the preleaching step is adjusted to maximise recovery of the at least one base metal using solvent extraction techniques.
[0022] Arsenic present in the solution may be caused to precipitate as ferric arsenate by increasing the pH of the solution to at least 2.
[0023] The pH of the solution may be increased by the addition of limestone slurry to the solution.
[0024] The pH adjustment may be carried out in a series of continuously stirred tank reactors which are operated at a temperature of from 60°C to 80°C.
[0025] The at least one base metal, eg. copper, may be recovered by concentrating the copper and stripping, followed by cathode production by electrowinning. BRIEF DESCRIPTION OF THE DRAWING
[0026] The invention is further described by way of example with reference to the accompanying drawing which is a flow sheet illustrating various steps in a method of treating a concentrate obtaining at least one base metal in accordance with the principles of the invention.
DESCRIPTION OF PREFERRED EMBODIMENT
[0027] In the method of the invention a concentrate 10 which contains a base metal such as copper and which may have a high arsenic content is subjected to a preleaching step 12. In this step the fresh concentrate is contacted with bioleach overflow solutions 14 and 16 respectively produced in subsequent primary and thermophilic secondary bioleaching stages 18 and 20.
[0028] The solutions 14 and 16 are rich in ferric and remove easily leachable copper from the feed 10. This ensures a lower residual copper tenor in the bioleaching tanks in the stages 18 and 20.
[0029] The product 22 of the preleaching stage is subjected to solid/liquid separation
24. An overflow solution 26 from the separation step 24 is directed to a pH adjustment stage 28 while the underflow 30, diluted with water 32 and raffinate 34 from a solvent extraction section 36, is fed to the primary bioleaching stage 18.
[0030] The purpose of the primary bioleaching stage 18 is to oxidise sulphide minerals in the feed and release base metals of interest into solution. The bioleaching is carried out in a series of continuously stirred tank reactors which are operated at a temperature of 35°C to 50°C in the presence of active quantities of mesophilic and moderate thermophilic microorganisms.
[0031] The pH of the pulp of the reactors in the primary bioleaching stage is controlled at a value of from 1 ,2 to 1 ,7 by the addition of limestone 40 or raffinate 34. Oxygen 42, required for the oxidative reaction, is supplied in the form of enriched air with an oxygen content of from 95% to 98%.
[0032] By operating the primary bioleaching stage 18 under the aforementioned conditions the oxidation of the sulphide minerals and the mass loss are maximised while, if arsenic is present in the feed, the precipitation thereof in pentavalent form is minimised.
[0033] The product 44 of the primary bioleaching section 18 reports to bioleach thickening and washing 46. As has been indicated the overflow solution 14 is fed to the preleaching step 12 while the underflow 48 is the feed to a metal recovery section 50.
[0034] The purpose of the step 46 is to separate the liquids and the solids so that the base metals of interest and arsenic, if present, report to the pH adjustment section 28 via the preleaching step 12. In the metal recovery step 50 toxic silver 52 is removed from the primary bioleaching residue 48 using a brine leaching or other suitable method.
[0035] The residue 54 from the metal recovery step is repulped with water 56 and raffinate 34 and the resulting slurry is fed to the thermophilic secondary bioleaching stage 20. [0036]The purpose of the stage 20 is to oxidise, to the extent possible, the sulphide minerals and the elemental sulphur which were not leached in the primary bioleaching stage 18. The base metals of interest are thereby released into solution. The thermophilic secondary bioleaching process is carried out in a series of continuously stirred tank reactors which are operated at a temperature of from 65°C to 80°C in the presence of active quantities of extreme thermophilic microorganisms.
[0037] The pH of the pulp in the thermophilic reactors is controlled at a value of from 1 ,0 to 1 ,7 by the addition of limestone 40 or raffinate 34. Oxygen 42 required for the oxidative reactions is supplied in the form of enriched gas with an oxygen content of from 95% to 98%. Carbon dioxide 57 may be required for improved thermophilic cell growth is supplied in the form of enriched gas with a carbon dioxide content of 1% to 5% by volume. By operating the thermophilic secondary bioleaching sections under these conditions the oxidation of the sulphide minerals and the mass loss are maximised while the precipitation of arsenic which may be present in the slurry 54, in the form of pentavalent arsenic, is minimised.
[0038] The product 60 of the thermophilic bioleaching section 20 reports to a bioleach thickening and washing step 62. The overflow solution 16 is fed to the preleaching section 12 while the underflow 64 is directed to a tailings pond 66 for disposal. If the underflow 64 contains PGM's then the underflow is directed to a metal recovery step 67 where the metal is removed from the underflow using cyanide as a leaching process for gold or other suitable method. [0039] The purpose of the step 62 is to separate liquid and solids so that base metals of interest and arsenic, if present, are reported in solution to the pH adjustment section 28 via the preleaching stage 12.
[0040] The pH adjustment section 28 includes a series of continuously stirred tank reactors which are operated at a temperature of from 60°C to 80°C. The pH of the solution 26 is increased to a required level using limestone 40 or any other suitable neutralising agent. The product 70 of the pH adjustment section is then thickened in a step 72. The thickener underflow 74, which contains precipitated ferric arsenate, is directed to a tailings pond 76 for disposal. The overflow from the thickener step reports as pregnant leach solution (PLS) 80 to the solvent extraction section 36.
[0041] The purpose of the pH adjustment section 28 is to increase the pH of the pregnant leach solution, which is fed to the solvent extraction section 36, to above 2,0 so that the solvent extraction efficiency is maximised. Arsenic which- is present in: the solution 26 is caused, by the increase in the pH, to precipitate primarily as ferric arsenate which is not readily dissolved. The ferric arsenate passes EPA limits and is safe for land disposal.
[0042] In the solvent extraction section 36 dissolved copper is recovered from the pregnant leached solution. The copper is stripped followed by cathode production (84) by electrowinning.
[0043] In the process of the invention the base metal containing concentrate is subjected to primary mesophilic and or moderate thermophilic leaching, metal recovery and thermophilic secondary leaching in combination so that secondary sulphides are successfully and economically leached in the primary section, toxic silver is removed in the metal recovery section, and a residue containing unleached primary sulphides and elemental sulphur is leached to completion successfully and economically in the thermophile secondary section. If arsenic is present in the concentrate the primary and thermophilic secondary sections are operated so that the redox potential of the solutions produced result in the natural oxidation of As(lll) to As(V). Arsenic precipitation in the bioleaching sections is intentionally minimised so that the arsenic is precipitated externally in the pH adjustment section 28. This avoids the production of a bioleach residue contaminated with arsenic.
[0044] It is cost effective to reduce the arsenic reporting to the thermophilic stage 20 by causing the arsenic to precipitate in a separate dedicated process step ie. the pH adjustment section 28. By minimising precipitation in the mesophilic stage 18 the mass loss throughout the process is maximised. This reduces the capital and operating cost of the downstream processes including the thermophilic section 20.
[0045] Furthermore sulphur oxidation at thermophilic temperature conditions is maximised and thus any elemental sulphur produced during the proceeding preleach and primary bioleach may be fully oxidised. This is important if further treatment of the thermophilic secondary bioleach residue is required for precious group metals (PGM's) recovery like gold. Elemental sulphur increases cyanide consumption during cyanidation to recover gold and thus contributes significantly to the increase in cyanidation costs. Additionally, elemental sulphur not oxidised decreases the acid produced in the bioleach solution and thus may decrease the effectiveness of any preleach step using recycled bioleach solution.

Claims

1. A method of treating a concentrate containing at least one base metal which includes the steps of subjecting the concentrate to a primary mesophilic and moderate thermophilic bioleaching process to leach sulphides in the concentrate, processing a residue of the primary bioleach process to recover at least one metal from the primary bioleach residue, subjecting a residue from the metal recovery process to a thermophilic secondary bioleaching process to release the at least one base metal from the metal recovery residue into solution, and recovering the at least one base metal at least from the solution produced by the thermophilic secondary bioleaching process.
2. A method according to claim 1 wherein the primary bioleaching process is carried out at a temperature of from 35°C to 50°C.
3. A method according to claim 1 or 2 wherein the at least one base metal is also recovered from a solution produced by the primary bioleach bioleaching process.
4. A method according to any one of claims 1 to 3 which includes the step of preleaching the concentrate, before the primary bioleach bioleaching process, using leach solution from at least one of the bioleaching processes.
5. A method according to claim 4 wherein the leach solution is derived from the primary bioleaching process and the thermophilic secondary bioleaching process.
6. A method according to claim 4 or 5 wherein the preleaching step is used to remove easily leachable base metal from the concentrate before the primary bioleaching process.
7. A method according to claim 4, 5 or 6 wherein elemental sulphur which accumulates during the preleach step due to rapid leaching of easily leachable sulphides is removed during the bioleaching stages.
8. A method according to any one of claims 4 to 7 which includes the step of adjusting the pH of a solution produced in the preleaching step to maximise recovery of the at least one base metal using solvent extraction techniques.
9. A method according to claim 8 which includes the step of causing arsenic in the solution to precipitate as ferric arsenate by increasing the pH of the solution to at least 2.
10. A method according to claim 8 or 9 wherein the pH adjustment is carried out at a temperature of from 60°C to 80°C.
11. A method according to any one of claims 1 to 10 wherein the primary bioleaching process is carried out in a series of continuously stirred tank reactors which are operated at a temperature of from 35°C to 50°C in the presence of an active mixed culture of mesophilic and moderate thermophilic microorganisms.
12. A method according to any one of claims 1 to 11 wherein a mixed culture of mesophile and moderate thermophile microorganisms are used to maximise sulphide bioleaching and sulphur biooxidation during the primary bioleaching process.
13. A method according to claim 12 wherein the mixed culture contains. Leptospiήllum ferrooxidans and Acidithiobacillus caldus.
14. A method according to claim 12 or 13 wherein the mixed culture of microorganims also contains thermophilic microorganims, which are not effectively active at the temperature range of 35°C to 50°C.
15. A method according to any one of claims 1 to 14 wherein the pH of the concentrate during the primary bioleaching processes is controlled at a value of from 1 ,2 to 1,7.
16. A method according to any one of claims 1 to 15 which includes the step of supplying air with an oxygen content of from 95% to 98% to the concentrate during at least part of the bioleaching processes.
17. A method according to any one of claims 1 to 16 which includes the step of removing toxic silver from the primary bioleaching residue.
18. A method according to any one of claims 1 to 17 wherein the thermophilic secondary bioleaching process is carried out at a temperature of from 65°C to 80°C in the presence of active quantities of extreme thermophilic microorganims.
19. A method according to any one of claims 1 to 18 which includes the step of controlling the pH of the concentrate during the secondary bioleaching process at a value of from 1 ,0 to 1 ,7.
20. A method according to any one of claims 1 to 19 which includes the step of supplying air with a carbon dioxide content of from 1% to 5% to the concentrate during at least part of the bioleaching processes.
21. A method according to any one of claims 1 to 20 wherein the at least one base metal is copper which is recovered by concentrating the copper and stripping, followed by cathode production by electrowinning.
PCT/ZA2004/000052 2003-05-19 2004-05-15 Treatment of base metal concentrate by a two-step bioleaching process WO2004101834A2 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
US10/557,410 US20070028721A1 (en) 2003-05-19 2004-05-15 Treatment of base metal concentrate by a two-step bioleaching process
AP2005003447A AP1973A (en) 2003-05-19 2004-05-15 Treatment of base metal concentrate by a two-step bioleaching process
AU2004239345A AU2004239345B2 (en) 2003-05-19 2004-05-15 Treatment of base metal concentrate by a two-step bioleaching process
CA 2526104 CA2526104A1 (en) 2003-05-19 2004-05-15 Treatment of base metal concentrate

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ZA200303621 2003-05-19
ZA2003/3621 2003-05-19

Publications (2)

Publication Number Publication Date
WO2004101834A2 true WO2004101834A2 (en) 2004-11-25
WO2004101834A3 WO2004101834A3 (en) 2005-03-03

Family

ID=33453094

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/ZA2004/000052 WO2004101834A2 (en) 2003-05-19 2004-05-15 Treatment of base metal concentrate by a two-step bioleaching process

Country Status (9)

Country Link
US (1) US20070028721A1 (en)
CN (1) CN100339493C (en)
AP (1) AP1973A (en)
AR (1) AR044408A1 (en)
AU (1) AU2004239345B2 (en)
CA (1) CA2526104A1 (en)
PE (1) PE20050453A1 (en)
WO (1) WO2004101834A2 (en)
ZA (1) ZA200509214B (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105087900A (en) * 2015-05-25 2015-11-25 厦门紫金矿冶技术有限公司 Dearsenification method of gold concentrates
US9885095B2 (en) 2014-01-31 2018-02-06 Goldcorp Inc. Process for separation of at least one metal sulfide from a mixed sulfide ore or concentrate

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000023629A1 (en) * 1998-10-16 2000-04-27 Mintek Process for bioleaching of copper concentrates
EP1050593A1 (en) * 1999-05-05 2000-11-08 Boliden Mineral Ab Two-stage bioleaching of sulphidic materials containing metal values and arsenic
US6383255B1 (en) * 1999-06-22 2002-05-07 Boliden Mineral Ab Method for recovering the valuable metal content of a sulphuric acid leaching solution

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1214043A (en) * 1983-01-26 1986-11-18 Albert Bruynesteyn Biological-acid leach process
AU714364C (en) * 1997-03-27 2002-05-02 Billiton S.A. Limited Recovery of copper
AUPP444298A0 (en) * 1998-07-01 1998-07-23 Bactech (Australia) Pty Limited Leaching of low sulphur ores
US7018593B1 (en) * 1999-09-01 2006-03-28 Billiton Sa Limited Base metal recovery from a tailings dump by bacterial oxidation
US6245125B1 (en) * 1999-09-15 2001-06-12 Billiton S.A. Limited Copper, nickel and cobalt recovery
US7314604B1 (en) * 1999-09-30 2008-01-01 Billiton Intellectual Property, B.V. Stable ferric arsenate precipitation from acid copper solutions whilst minimising copper losses

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000023629A1 (en) * 1998-10-16 2000-04-27 Mintek Process for bioleaching of copper concentrates
EP1050593A1 (en) * 1999-05-05 2000-11-08 Boliden Mineral Ab Two-stage bioleaching of sulphidic materials containing metal values and arsenic
US6383255B1 (en) * 1999-06-22 2002-05-07 Boliden Mineral Ab Method for recovering the valuable metal content of a sulphuric acid leaching solution

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9885095B2 (en) 2014-01-31 2018-02-06 Goldcorp Inc. Process for separation of at least one metal sulfide from a mixed sulfide ore or concentrate
US10370739B2 (en) 2014-01-31 2019-08-06 Goldcorp, Inc. Stabilization process for an arsenic solution
US11124857B2 (en) 2014-01-31 2021-09-21 Goldcorp Inc. Process for separation of antimony and arsenic from a leach solution
CN105087900A (en) * 2015-05-25 2015-11-25 厦门紫金矿冶技术有限公司 Dearsenification method of gold concentrates

Also Published As

Publication number Publication date
AP1973A (en) 2009-03-12
PE20050453A1 (en) 2005-06-23
CA2526104A1 (en) 2004-11-25
AU2004239345A1 (en) 2004-11-25
WO2004101834A3 (en) 2005-03-03
US20070028721A1 (en) 2007-02-08
AP2005003447A0 (en) 2005-12-31
ZA200509214B (en) 2006-09-27
AU2004239345B2 (en) 2008-09-25
AR044408A1 (en) 2005-09-14
CN1697887A (en) 2005-11-16
CN100339493C (en) 2007-09-26

Similar Documents

Publication Publication Date Title
CA2305052C (en) Bioleaching sulfidic materials
EP1644542B1 (en) Oxidative leach process
AU763302C (en) Integrated, tank/heap biooxidation process for the lixiviation of sulfide ores
US6245125B1 (en) Copper, nickel and cobalt recovery
WO2007039664A1 (en) Sodium chloride processing of nickel sulphide ore or concentrates
US7514050B2 (en) Processing of acid-consuming mineral materials involving treatment with acidic biooxidation effluent
US7314604B1 (en) Stable ferric arsenate precipitation from acid copper solutions whilst minimising copper losses
Sadeghieh et al. Effect of water salinity on the bioleaching of copper, nickel and cobalt from the sulphidic tailing of Golgohar Iron Mine, Iran
US6280501B1 (en) Base metal recovery
CA2559243C (en) Method for bioleaching metal containing sulphidic materials
US6921426B2 (en) Process of recovering copper from ore
MXPA01003809A (en) Process for bioleaching of copper concentrates.
AU2004239345B2 (en) Treatment of base metal concentrate by a two-step bioleaching process
CA2282848C (en) Copper and nickel recovery
US6103204A (en) Selective bioleaching of zinc
WO2000037690A1 (en) Silver-catalyzed bio-leaching process for copper extraction from chalcopyrite heap
GB2291869A (en) Recovering nickel from sulphide ore
RU2234544C1 (en) Method of reworking of auriferous arsenical ores and concentrates
US6379919B1 (en) Method for isolating thiocyanate resistant bacteria
AU745120B2 (en) Selective bioleaching of zinc
Jena et al. K. Melal and Mineral Recov-ery Through Bioleaching
AU2004217870A1 (en) Microorganism and method for leaching mineral sulphides

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 20048000311

Country of ref document: CN

AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DPEN Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed from 20040101)
WWE Wipo information: entry into national phase

Ref document number: AP/P/2005/003447

Country of ref document: AP

WWE Wipo information: entry into national phase

Ref document number: 200509214

Country of ref document: ZA

WWE Wipo information: entry into national phase

Ref document number: 2526104

Country of ref document: CA

Ref document number: 2004239345

Country of ref document: AU

ENP Entry into the national phase

Ref document number: 2004239345

Country of ref document: AU

Date of ref document: 20040515

Kind code of ref document: A

WWP Wipo information: published in national office

Ref document number: 2004239345

Country of ref document: AU

122 Ep: pct application non-entry in european phase
WWE Wipo information: entry into national phase

Ref document number: 2007028721

Country of ref document: US

Ref document number: 10557410

Country of ref document: US

WWP Wipo information: published in national office

Ref document number: 10557410

Country of ref document: US